Journal
CELLULAR & MOLECULAR IMMUNOLOGY
Volume 6, Issue 2, Pages 97-103Publisher
CHIN SOCIETY IMMUNOLOGY
DOI: 10.1038/cmi.2009.13
Keywords
Epstein-Barr Virus; latent membrane protein 2A; epitope; cytotoxic T lymphocyte
Categories
Funding
- National Nature Science Foundation of China [30571715]
Ask authors/readers for more resources
Epstein-Barr virus (EBV) associated nasopharyngeal carcinoma (NPC) is a high incidence tumor in Southeast Asia. Among EBV encoded proteins, latent membrane protein 2A (LMP2A) is an important antigen for T cell therapy of EBV. In this study, we predicted six HLA-A2 restricted cri, candidate epitopes of LMP2A by SYFPEITHI, NetMHC and MHCPred methods combined with the polynomial method. Subsequently, biological functions of these peptides were tested by experiments in vitro. In ELISPOT assay, the positive response of the LMP2A specific cri. stimulated by three (LMP2A(264-272), LMP2A(426-434) and LMP2A(356-364)) of six peptides respectively showed that the numbers of spots forming cells (SFC) ranged from 55.7 to 80.6 SFC/5 x 10 CD8(+) T cells and the responding index (RI) ranged from 5.4 to 7. These three epitope-specific CTLs could effectively kill specific HLA-A2-expressing target cells. As a result, LMP2A(264-272) (QLSPLLGAV), LMP2A(426-434) (CLGGLLTMV) and LMP2A(356-364) (FLYALALLL) were identified as LMP2A-specific CD8(+) T-cell epitopes. It would be useful to clarify immune response toward EBV and to develop a vaccine against EBV-correlative NPC. Cellular & Molecular Immunology. 2009;6(2):97-103.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available